You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 195 Avelumab internalization and lysosomal degradation by circulating immune cells in human is mediated by both Fc gamma Receptor (FcgR) and PD-L1 binding

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Checkpoint blockade therapy
195 Avelumab internalization and lysosomal degradation by circulating immune cells in human is mediated by both Fc gamma Receptor (FcgR) and PD-L1 binding

 

Online download statistics by month:

Online download statistics by month: November 2020 to August 2024

AbstractFullPdf
Nov 202088013
Dec 202060015
Jan 20216707
Feb 202139010
Mar 202164011
Apr 202154019
May 20217014
Jun 20210015
Jul 20210029
Aug 20210021
Sep 20210011
Oct 202136028
Nov 202172020
Dec 20212604
Jan 20223602
Feb 20222404
Mar 202228010
Apr 20225807
May 20223805
Jun 20225208
Jul 20224804
Aug 202244014
Sep 20223407
Oct 20224408
Nov 20223204
Dec 20223008
Jan 20232802
Feb 20233603
Mar 20234607
Apr 20233406
May 20231803
Jun 20231801
Jul 20231603
Aug 20233806
Sep 20232200
Oct 20232904
Nov 20233203
Dec 20234800
Jan 20241001
Feb 20242003
Mar 20243401
Apr 20244202
May 20243000
Jun 20242403
Jul 20242201
Aug 20242603
Total15540350